pyrazole has been researched along with allyl sulfide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cederbaum, AI; Wu, D | 1 |
Cederbaum, AI; MarĂ, M; Nieto, N | 1 |
Clemens, DL; Dey, A; Swaminathan, K | 1 |
Clemens, DL; Dey, A; Kumar, SM; Swaminathan, K | 1 |
4 other study(ies) available for pyrazole and allyl sulfide
Article | Year |
---|---|
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes.
Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chromans; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Synergism; Hepatocytes; Humans; Lipid Peroxidation; Male; Mixed Function Oxygenases; Protein Synthesis Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Salicylate; Sulfides | 2001 |
Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit.
Topics: 5' Flanking Region; Allyl Compounds; Animals; Antioxidants; Arachidonic Acid; Carcinoma, Hepatocellular; Catalase; Catalytic Domain; Central Nervous System Depressants; Cytochrome P-450 CYP2E1; Enzyme Inhibitors; Ethanol; Gene Deletion; Gene Expression; Genes, Reporter; Glutamate-Cysteine Ligase; Glutathione; Humans; Iron; Liver Neoplasms; Luciferases; Promoter Regions, Genetic; Pyrazoles; Rats; Response Elements; RNA, Messenger; Sulfides; Tumor Cells, Cultured | 2003 |
Inhibition of CYP2E1 leads to decreased malondialdehyde-acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposure.
Topics: Acetaldehyde; Alcohol Dehydrogenase; Allyl Compounds; Apoptosis; Caspase 3; Cell Line; Cell Survival; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Drug Administration Schedule; Enzyme Inhibitors; Ethanol; Fomepizole; Hep G2 Cells; Humans; Malondialdehyde; Pyrazoles; Reactive Oxygen Species; Sulfides | 2013 |
Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells.
Topics: Alcohol Dehydrogenase; Allyl Compounds; Cell Line; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Glucose; Glycation End Products, Advanced; Humans; Oxidative Stress; Pyrazoles; Reactive Oxygen Species; Sulfides | 2013 |